The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.
Dr. Brian Caveney is the Chief Medical Officer and President of Labcorp Diagnostics ... doctors will want to rule out COVID for sure, but also potentially test for influenza in a person where ...
On the 5-year anniversary of the start of the COVID-19 pandemic, CEOs said the crisis taught them to respond faster and ...
A promising orally bioavailable once-daily form has been an animal test by our partner Entera Bio ... to accelerate our development of the COVID multispecific antibody and $16 million into ...
This test, developed in collaboration ... The firm highlighted LabCorp's emergence from a period of significant challenges due to COVID-19 and the company's shift in focus to more successful ...
The United States government will no longer issue free COVID-19 tests. Here are some places near you where you can get them ...
Labcorp Plasma Complete is a laboratory-developed test (LDT) and was validated in Labcorp's College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA ...
You can no longer order free COVID-19 tests from the United States government. As of March 10, the government's free ...
The liquid biopsy test enables oncologists to perform comprehensive genomic profiling to inform personalized treatment decisions – all from a simple blood draw. Labcorp Plasma Complete detects ...
WASHINGTON — The U.S. government's free at-home COVID-19 test distribution program has been suspended and is no longer ...
As of Monday, March 10, the federal government's free COVID test distribution program is not currently accepting orders, according to the Administration for Strategic Preparedness and Response's ...
The liquid biopsy test enables oncologists to perform comprehensive genomic profiling to inform personalized treatment decisions – all from a simple blood draw. "Labcorp Plasma Complete delivers ...